Company intelligence / Profile preview

Eximo Medical

Rehovot, Central District, Israelfinder.startupnationcentral.org ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Eximo Medical developed a proprietary hybrid catheter platform for the treatment of complex vascular lesions. The company completed a successful multi-center first-in-human trial in Europe for treating complex lesions in peripheral blood vessels. Its technology was recognized with an Innovative Company Award at the IDSS Electrophysiology Conference in 2016.

Therapeutic areas: GastroenterologyCardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Auryon

Commercial

Indications: Peripheral Artery Disease, In-stent Restenosis

Beyond the preview

Go deeper on Eximo Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eximo Medical.

Explore the full profile